Mouhammad A. Habra

Mouhammad A. Habra is a High Senior Professor at The University of Texas MD Anderson Cancer Center. His research focuses on endocrine oncology, with a particular emphasis on adrenocortical carcinoma, adrenal disease, and the molecular pathology of cancer. His recent work includes pioneering studies on adjuvant radiation therapy and computed tomography-based prognostic scoring for adrenocortical carcinoma, as well as investigations into β-catenin’s role as a molecular adapter in cBAF interactions. He has also explored the manifestation of adrenocortical carcinoma in Birt–Hogg–Dubé syndrome and the efficacy of gemcitabine-oxaliplatin combination therapy for advanced disease. His contributions span pharmacology, urology, and radiation oncology, advancing both clinical management and translational cancer research.